Is a complete INBX research report available?

No complete published report is available for Inhibrx Biosciences, Inc. (INBX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Inhibrx Biosciences, Inc. (INBX)

NASDAQ: INBX · USD

$84.7

+5.48 (+6.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first INBX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	1.2B
Revenue (ttm)	1.3M
Net income (ttm)	-130.2M
EPS (ttm)	-$8.39
Shares out	14.7M
Volume	275,496
Beta	3.42
Price target	$278	+227.5%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3M
Net income (ttm): -130.2M
EPS (ttm): -$8.39
Market cap: 1.2B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All INBX indicators

Market & fundamental data

Available fields

196

Groups with data

Currency

USD

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001739614
Company name	Inhibrx Biosciences, Inc.
Country	United States
Country code	US
Cusip	45720N103
Employees	110
Employees Change	-51%
Employees Change Percent	-31.68
Enterprise value	$1.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2020-08-19
Isin	US45720N1037
Last refreshed	2026-07-31
Market cap	$1.2B
Market cap category	Small-Cap
Price	$84.73
Price currency	USD
Rev Per Employee	11,818.18x
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Sic	2836
Symbol	INBX
Website	https://inhibrx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-10.47%
EV Sales Forward	131.49x
EV/Sales	971.02x
FCF yield	-10.61%
P/S ratio	956.22x
PS Forward	129.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-100.1M
Net Income	$-130.2M
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Pretax Margin	-10,014.08%
Profit Per Employee	$-1.2M
ROA	-36.06
Roa5y	-62.33
ROCE	-78.15
ROE	-354.7
Roe5y	-52.96
ROIC	-166

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	249.56%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth	550x
Revenue Growth Years	1x
Revenue Growth3 Y	47.76x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$184M
Cash	$161.7M
Current Assets	$171.3M
Current Liabilities	$26.5M
Debt	$180.9M
Equity	$-21M
Interest Coverage	-9.45
Liabilities	$205M
Long Term Assets	$12.6M
Long Term Liabilities	$178.5M
Net Cash	$-19.2M
Net Cash By Market Cap	$-1.55
Tangible Book Value	$-21M
Tangible Book Value Per Share	$-1.44
WACC	20.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.46
Inventory Turnover	58.85
Net Working Capital	$-14.4M
Quick ratio	6.1
Working Capital	$144.8M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.49%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	249.26%
200-day SMA	83.55
50-day SMA	93.85
50-day SMA vs 200-day SMA	50over200
All Time High	155.3
All Time High Change	-45.44%
All Time High Date	2026-04-22
All Time Low	10.8
All Time Low Change	684.54%
All Time Low Date	2024-08-12
ATR	5.93
Beta	3.42
Beta1y	3.25
Beta2y	1.36
Ch YTD	7.25
High	85.47
High52	155.3
High52 Date	2026-04-22
High52ch	-45.44%
Low	79.67
Low52	20.55
Low52 Date	2025-08-08
Low52ch	312.31%
Ma50ch	-9.72%
Premarket Change Percent	2.47
Premarket Price	$81.21
Premarket Volume	850
Price vs 200-day SMA	1.41%
RSI	43.27
RSI Monthly	62.07
RSI Weekly	49.27
Sharpe ratio	1.42x
Sortino ratio	3.86
Total Return	-0.49%
Tr YTD	7.25
Tr1m	-11.28%
Tr1w	-0.32%
Tr3m	-32.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	1
Analyst Price Target Top	$230
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-2.32
Operating Income	$-123.1M
Operating margin	-9,465.5
Price target	$278
Price Target Change	$228
Price Target Change Top	$171

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,369,454%
Float Percent	57.05%
Net Borrowing	74,992,000
Shares Insiders	15.26%
Shares Institutions	61.21%
Shares Out	14,671,186
Shares Qo Q	0.33%
Shares Yo Y	0.49%
Short Float	41.03%
Short Ratio	9.33
Short Shares	23.41

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-143.3M
Adjusted OCF	-143,266,000
Average Volume	300,949.9x
Bv Per Share	-1.44
CAPEX	$-10,000
Ch1m	-11.28
Ch1w	-0.32
Ch1y	249.3
Ch3m	-32.12
Ch6m	16.77
Change	6.91%
Change From Open	4.59
Close	79.25
Days Gap	2.22
Depreciation Amortization	2,345,000
Dollar Volume	23,342,776.1
Earnings Date	2026-08-13
Earnings Time	amc
EBIT	$-123.1M
EBITDA	$-120.7M
EPS	$-8.39
F Score	3
FCF	$-131.9M
FCF EV Yield	-10.45x
FCF Per Share	$-8.99
Financing CF	77,069,000
Fiscal Year End	December
Founded	2,010
Income Tax	$2,000
Investing CF	-7,000
Ipr	398.4
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2024-02-28
Ma150	87.33
Ma150ch	-2.98%
Ma20	89.64
Ma20ch	-5.48%
Net CF	-54,863,000
Next Earnings Date	2026-08-12
Open	81.01
Optionable	Yes
Position In Range	87.24
Post Close	84.73
Postmarket Change Percent	0.45
Postmarket Price	$85.11
Ppne	8,248,000
Pre Close	79.25
Price Date	2026-07-30
Relative Volume	0.92x
Revenue	1,300,000x
SBC By Revenue	872.38x
Share Based Comp	11,341,000
Tax By Revenue	0.15x
Tr6m	16.77%
Us State	California
Volume	275,496
Z Score	-1.48

Inhibrx Biosciences, Inc. (INBX)

Coverage state: Market snapshot only — no published research

Generate the first INBX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · INBX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INBX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on INBX

Frequently asked questions